Quantum Genomics' Unattributed Round

Quantum Genomics raised a round of funding on March 31, 2016. Investors include Sabby Management.

Quantum Genomics is a biopharmaceutical company dedicated to developing new therapies for unmet medical needs in the field of cardiovascular diseases, including hypertension and heart failure.…

Articles about Quantum Genomics' Unattributed Round: